Choose your country and language

You are currently on

UK

UK

Managing COVID-19 in OBGYN and MFM settings

icon-doc.svg
Category
Clinical Bulletins

Critical Summary

  • Pregnant women may be at greater risk from complications should they acquire COVID-19, caused by the enveloped virus SARS-CoV-2.
  • SARS-CoV-2 can survive on surfaces for days, and one study has reported survival in aerosols for >3 hours.
  • It is imperative infection prevention efforts are maximised in the OB/GYN and MFM setting to mitigate transmission risk to pregnant patients.
  • Guidance from professional societies provide advice on infection prevention strategies, including ultrasound equipment disinfection, to minimize infection risks.
THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC
THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC